Ticker
ABIO

Price
3.33
Stock movement down
-0.67 (-16.75%)
Company name
ARCA Biopharma Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
47.99M
Ent value
6.95M
Price/Sales
-
Price/Book
1.15
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-53.56%
1 year return
57.82%
3 year return
0.51%
5 year return
-18.57%
10 year return
-32.62%
Last updated: 2024-05-17

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

ABIO does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book1.15
EV to Sales-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count14.41M
EPS (TTM)-0.69
FCF per share (TTM)-0.76

Income statement

Loading...
Income statement data
Revenue (TTM)0.00
Gross profit (TTM)0.00
Operating income (TTM)-10.60M
Net income (TTM)-9.93M
EPS (TTM)-0.69
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash42.45M
Net receivables0.00
Total current assets42.70M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets43.09M
Accounts payable334.00K
Short/Current long term debt280.00K
Total current liabilities1.13M
Total liabilities1.41M
Shareholder's equity41.67M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-10.91M
Capital expenditures (TTM)2.00K
Free cash flow (TTM)-10.91M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-23.82%
Return on Assets-23.04%
Return on Invested Capital-23.82%
Cash Return on Invested Capital-26.19%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open4.09
Daily high4.49
Daily low3.11
Daily Volume456K
All-time high5726700.00
1y analyst estimate7.00
Beta1.46
EPS (TTM)-0.69
Dividend per share-
Ex-div date1 May 2006
Next earnings date19 Jul 2024

Downside potential

Loading...
Downside potential data
ABIOS&P500
Current price drop from All-time high-100.00%-0.06%
Highest price drop-100.00%-56.47%
Date of highest drop2 Apr 20249 Mar 2009
Avg drop from high-94.15%-11.32%
Avg time to new high293 days13 days
Max time to new high6100 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
ABIO (ARCA Biopharma Inc) company logo
Marketcap
47.99M
Marketcap category
Small-cap
Description
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydrochloride), a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure. ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial; and research collaboration with Colorado Prevention Center, the University of Colorado's Academic Research Organization to develop and commercialize Gencaro. The company was incorporated in 2004 and is headquartered in Westminster, Colorado.
Employees
5
Investor relations
-
SEC filings
CEO
Michael R. Bristow
Country
USA
City
Westminster
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...